Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,150,871 papers from all fields of science
Search
Sign In
Create Free Account
tyrphostin AG957
Known as:
AG957
, Tyrphostin AG 957
, AG 957
Expand
A member of the tyrphostin family of tyrosine kinase inhibitors that selectively inhibits human p210 tyrosine kinase activity. (NCI)
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (3)
Benzylidene Compounds
Nitriles
Tyrphostins
Receptor Tyrosine Kinase Inhibition
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Inhibition of fast sodium current in rabbit ventricular myocytes by protein tyrosine kinase inhibitors
Yanggan Wang
,
M. Wagner
,
R. Kumar
,
Jun Cheng
,
R. W. Joyner
Pflügers Archiv
2003
Corpus ID: 24852685
The present study investigated the effects of protein tyrosine kinase inhibitors on the fast sodium current (INa) in rabbit…
Expand
2003
2003
Two-step formation of 1H NMR visible mobile lipids during apoptosis of paclitaxel-treated K562 cells.
F. Brisdelli
,
E. Iorio
,
+6 authors
A. Bozzi
Biochemical Pharmacology
2003
Corpus ID: 35411855
2002
2002
In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines
I. Avramis
,
G. Christodoulopoulos
,
+5 authors
V. Avramis
Cancer Chemotherapy and Pharmacology
2002
Corpus ID: 25594021
Abstract Purpose.NSC 680410, the novel adamantyl ester of AG957, an inhibitor of the p210bcr/abl tyrosine kinase (CML, Ph+) and…
Expand
Review
2001
Review
2001
Cell adhesion is a key determinant in de novo multidrug resistance (MDR): new targets for the prevention of acquired MDR.
K. Shain
,
W. Dalton
Molecular Cancer Therapeutics
2001
Corpus ID: 17522882
Clinical circumvention of multidrug resistance (MDR) is a Sisyphian task faced in the treatment of many cancers. Identification…
Expand
Highly Cited
2001
Highly Cited
2001
Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL--expressing cells, demonstrating synergy between AG490 and STI571.
X. Sun
,
J. Layton
,
A. Elefanty
,
G. Lieschke
Blood
2001
Corpus ID: 3048671
STI571 (formerly CGP57148) and AG957 are small molecule inhibitors of the protein tyrosine kinase (PTK) p145(abl) and its…
Expand
Highly Cited
2000
Highly Cited
2000
Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro.
P. Svingen
,
A. Tefferi
,
+4 authors
S. Kaufmann
Clinical Cancer Research
2000
Corpus ID: 15806102
The tyrphostin AG957 (NSC 654705) inhibits p210bcr/abl, the transforming kinase responsible for most cases of chronic myelogenous…
Expand
1999
1999
Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells.
C. Carlo-Stella
,
E. Regazzi
,
+8 authors
V. Rizzoli
Blood
1999
Corpus ID: 19339985
The hallmark of chronic myelogenous leukemia (CML) is the Philadelphia (Ph) chromosome that fuses genetic sequences of the BCR…
Expand
1998
1998
Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores β1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic…
R. Bhatia
,
H. Munthe
,
C. Verfaillie
Leukemia
1998
Corpus ID: 36487126
Abnormal β1 integrin receptor function may contribute to the continuous proliferation and abnormal circulation of malignant…
Expand
1996
1996
Altered physical state of p21bcr—abl in tyrphostin AG957-treated K562 cells
G. Kaur
,
E. Sausville
Anti-Cancer Drugs
1996
Corpus ID: 31479334
AG957 is a tyrosine kinase antagonist which prior studies had shown inhibits p2106bcr abl tyrosine kinase activity and K562…
Expand
Highly Cited
1994
Highly Cited
1994
Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia.
G. Kaur
,
A. Gazit
,
A. Levitzki
,
E. Stowe
,
D. Cooney
,
E. Sausville
Anti-Cancer Drugs
1994
Corpus ID: 19639573
We have examined a series of tyrosine kinase inhibitors structurally related to erbstatin (tyrphostins) for inhibition of p210bcr…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE